feed,title,long_url,short_url
Benzinga,Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug,https://benzinga.com/general/biotech/22/09/28794390/new-data-favors-higher-dose-of-regenerons-flagship-eye-disease-drug,https://bit.ly/3RuLe2H
Benzinga,Dow Drops 100 Points; US Jobless Claims Fall Further Last Week,https://benzinga.com/news/22/09/28795783/dow-drops-100-points-us-jobless-claims-fall-further-last-week,https://bit.ly/3D5OTQp
